MAPK1 and prostate carcinoma: Additionally, Yu et al. [59] reported that hsa-miR-92a-1-5p was overexpressed in extracellular vesicles of prostate cancer patients and promoted osteoclast differentiation by reducing MAPK1 and FoxO1 expression.